<DOC>
	<DOCNO>NCT00860808</DOCNO>
	<brief_summary>The purpose study evaluation therapeutic benefit intratympanic AM 101 injection comparison placebo treatment persistent acute inner ear tinnitus follow acute sensorineural hearing loss .</brief_summary>
	<brief_title>Efficacy AM 101 Patients With Acute Inner Ear Tinnitus</brief_title>
	<detailed_description>Tinnitus may seriously impact ability sleep , relax , concentrate , lead tiredness , irritation , nervousness , despair , frustration , depression , thus severely impact quality life health affect person . To date , exist pharmaceutical treatment persist tinnitus . Non-clinical study AM-101 show inhibition cochlear NMDA receptor successful suppress tinnitus without affect normal glutamate neurotransmission respectively hear function . In particular , could demonstrate local administration AM-101 single dose result complete suppression tinnitus induce acute acoustic trauma without relapse thereafter .</detailed_description>
	<mesh_term>Tinnitus</mesh_term>
	<criteria>Persistent tinnitus follow acute acoustic trauma , sudden deafness , acute otitis medium onset less three month ago ( i.e . acute tinnitus ) Tinnitus provoke incident acute acoustic trauma , sudden deafness acute otitis medium document audiogram medical report onset result inner ear hearing loss least 15 dB two adjacent frequency Minimum Masking Level ( MML ) least 5 dB SL Age ≥ 18 year ≤ 65 year Negative pregnancy test woman childbearing potential Willing able attend onstudy visit Must able read understand relevant study document Written inform consent participation study Tinnitus completely maskable Fluctuating tinnitus Intermittent tinnitus Meniere 's Disease Acute chronic otitis medium otitis externa Any ongoing therapy know potentially tinnitusinducing ( e.g . aminoglycosides , cisplatin , loop diuretic , high dos aspirin , quinine etc . ) Any drugbased therapy inner ear hear loss ongoing perform past 2 week , e.g . prednisolone , dexamethasone , pentoxifylline , betahistine , diazepam , carbamazepine , sodium valproate antidepressant Concomitant use NMDA receptor antagonist ( e.g . memantine , dextromethorphan , ifenprodil ) Any ongoing plan concomitant medication treatment tinnitus 90 day study drug application History presence drug abuse alcoholism Any clinically relevant respiratory , cardiovascular , neurological ( except vertigo ) , psychiatric disorder Known hypersensitivity , allergy intolerance study medication history severe abnormal drug reaction Women breastfeeding , pregnant plan pregnancy trial Women childbearing potential declare unwilling unable practice contraception hormonal contraceptive , sexual abstinence intercourse vasectomise partner Concurrent participation another clinical trial investigational drug participation another clinical trial investigational drug within 30 day prior study entry Any drugbased therapy otitis medium ongoing perform past 2 week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>tinnitus</keyword>
</DOC>